US 12233132
Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same
granted A61KA61K39/00A61K47/6935
Quick answer
US patent 12233132 (Polyoxazoline-lipid conjugates and lipid nanoparticles and pharmaceutical compositions including same) held by Serina Therapeutics, Inc. expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Serina Therapeutics, Inc.
- Grant date
- Tue Feb 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K39/00, A61K47/6935